Airain Ltd’s Iovance Biotherapeutics IOVA Stock Holding History

Airain Ltd’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-10,975	Closed	-$85K	–	930
2015 Q4	$85K	Buy	+10,975	New	+$76.2K	0.01%	777

Other funds holding IOVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Airain Ltd's IOVA Position: Q1 2016 in Review

Airain Ltd sold out of Iovance Biotherapeutics (IOVA) in Q1 2016, closing a stake of 10,975 shares — an estimated $85K sold.

Airain Ltd first reported a position in IOVA in Q4 2015 and held it in 1 quarter. The position peaked at $85K in Q4 2015. 77 funds tracked by Wall St. Rank hold IOVA as of Q1 2016.

Airain Ltd reported no remaining Iovance Biotherapeutics position as of Q1 2016 after selling out during the quarter.
Airain Ltd sold 10,975 Iovance Biotherapeutics shares in Q1 2016, an estimated $85K.
Airain Ltd first reported a position in Iovance Biotherapeutics in Q4 2015 and held it in 1 quarter.
Airain Ltd's Iovance Biotherapeutics position peaked at $85K in Q4 2015.
77 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2016.

Based on Airain Ltd's 13F filing for Q1 2016, filed 9 May 2016.